CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 48 enrolled
Drug / intervention
ACTIVA® PC neurostimulator (Model 37601)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02535884
NCT02535884N/ACompleted
CompareCT.gov

Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD): A Prospective, Randomised, Controlled, International, Multi-centre Study

Heinrich-Heine University, Duesseldorf·interventional·Posted Aug 31, 2015·Updated Jan 21, 2022

In Brief

A clinical study evaluating ACTIVA® PC neurostimulator (Model 37601) for Huntington Disease. Completed, enrolled 48 participants across 12 sites in 4 countries.

Detailed Summary

The aim of the study is to prove the efficacy and safety of pallidal DBS in HD patients and to show superiority of DBS on motor function in the stimulation group compared to stimulation-off group

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHuntington Disease
CountriesAustria, France, Germany, Switzerland
CollaboratorsKKS Netzwerk, Medtronic, The George Institute, Egyptian Society of Neurological Surgeons, CHDI Foundation, Inc.

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 31, 2015
Enrollment StartJul 1, 2014
Primary CompletionDec 31, 2021
TodayJul 2, 2026
Enrollment to primary: 7.5 yearsPosted 10.8 years ago

Interventions

ACTIVA® PC neurostimulator (Model 37601)device

the stimulator in the stimulation group will be turned on after implantation of the device